PGRMC1 and breast carcinoma: In contrast to the reports of the Mach group and co-workers, Abate, et al. demonstrated that PGRMC1 knockdown in MCF-7 breast cancer cells did not affect DTG (1,3-di-o-tolylguanidine) binding in membrane fractions [54].